{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:23:25Z","timestamp":1775003005878,"version":"3.50.1"},"publisher-location":"Cham","reference-count":46,"publisher":"Springer Nature Switzerland","isbn-type":[{"value":"9783032041524","type":"print"},{"value":"9783032041531","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-3-032-04153-1_7","type":"book-chapter","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T23:28:53Z","timestamp":1774999733000},"page":"91-107","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["New Sialic Acid-Binding Site of SIGLEC-7"],"prefix":"10.1007","author":[{"given":"Sayo","family":"Morishita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaya","family":"Hane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nao","family":"Yamakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Kitajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chihiro","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"7_CR1","doi-asserted-by":"publisher","first-page":"3372","DOI":"10.1074\/jbc.M210602200","volume":"278","author":"M Alphey","year":"2003","unstructured":"Alphey M, Attrill H, Crocker P, van Aalten D (2003) High resolution crystal structures of Siglec-7. Insights into ligand specificity in the Siglec family. J Biol Chem 278:3372\u20133377. https:\/\/doi.org\/10.1074\/jbc.M210602200","journal-title":"J Biol Chem"},{"key":"7_CR2","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1021\/cr000407m","volume":"102","author":"T Angata","year":"2002","unstructured":"Angata T, Varki A (2002) Chemical diversity in the sialic acids and related alpha-keto acids: an evolutionary perspective. Chem Rev 102:439\u2013469. https:\/\/doi.org\/10.1021\/cr000407m","journal-title":"Chem Rev"},{"key":"7_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2022.101117","volume":"90","author":"T Angata","year":"2023","unstructured":"Angata T, Varki A (2023) Discovery, classification, evolution and diversity of Siglecs. Mol Asp Med 90:101117. https:\/\/doi.org\/10.1016\/j.mam.2022.101117","journal-title":"Mol Asp Med"},{"key":"7_CR4","doi-asserted-by":"publisher","first-page":"32774","DOI":"10.1074\/jbc.M601714200","volume":"281","author":"H Attrill","year":"2006","unstructured":"Attrill H, Imamura A, Sharma RS, Kiso M, Crocker PR, van Aalten DM (2006) Siglec-7 undergoes a major conformational change when complexed with the alpha(2,8)-disialylganglioside GT1b. J Biol Chem 281:32774\u201332783. https:\/\/doi.org\/10.1074\/jbc.M601714200","journal-title":"J Biol Chem"},{"key":"7_CR5","doi-asserted-by":"publisher","first-page":"4133","DOI":"10.1128\/IAI.02094-05","volume":"74","author":"T Avril","year":"2006","unstructured":"Avril T, Wagner ER, Willison HJ, Crocker PR (2006) Sialic acid-binding immunoglobulin-like lectin 7 mediates selective recognition of sialylated glycans expressed on Campylobacter jejuni lipooligosaccharides. Infect Immun 74:4133\u20134141. https:\/\/doi.org\/10.1128\/IAI.02094-05","journal-title":"Infect Immun"},{"key":"7_CR6","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.trecan.2023.11.009","volume":"10","author":"K Boelaars","year":"2024","unstructured":"Boelaars K, van Kooyk Y (2024) Targeting myeloiells for cancer immunotherapy: Siglec-7\/9\/10\/15 and their ligands. Trends Cancer 10:230\u2013241. https:\/\/doi.org\/10.1016\/j.trecan.2023.11.009","journal-title":"Trends Cancer"},{"key":"7_CR7","doi-asserted-by":"publisher","first-page":"3822","DOI":"10.1182\/blood-2009-06-226332","volume":"114","author":"E Brunetta","year":"2009","unstructured":"Brunetta E, Fogli M, Varchetta S, Bozzo L, Hudspeth KL, Marcenaro E, Moretta A, Mavilio D (2009) The decreased expression of Siglec-7 represents an early marker of dysfunctional natural killer-cell subsets associated with high levels of HIV-1 viremia. Blood 114:3822\u20133830. https:\/\/doi.org\/10.1182\/blood-2009-06-226332","journal-title":"Blood"},{"key":"7_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.840388","volume":"13","author":"LY Chang","year":"2022","unstructured":"Chang LY, Liang SY, Lu SC, Tseng HC, Tsai HY, Tang CJ, Sugata M, Chen YJ, Wu SJ, Lin KI, Khoo KH, Angata T (2022) Molecular basis and role of Siglec-7 ligand expression on chronic lymphocytic leukemia B cells. Front Immunol 13:840388. https:\/\/doi.org\/10.3389\/fimmu.2022.840388","journal-title":"Front Immunol"},{"key":"7_CR9","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/j.1749-6632.2011.06304.x","volume":"1253","author":"MC Clark","year":"2012","unstructured":"Clark MC, Baum LG (2012) T cells modulate glycans on CD43 anD45 during development and activation, signal regulation, and survival. Ann N Y Acad Sci 1253:58\u201367. https:\/\/doi.org\/10.1111\/j.1749-6632.2011.06304.x","journal-title":"Ann N Y Acad Sci"},{"key":"7_CR10","doi-asserted-by":"publisher","first-page":"v","DOI":"10.1093\/oxfordjournals.glycob.a018832","volume":"8","author":"PR Crocker","year":"1998","unstructured":"Crocker PR, Clark EA, Filbin M, Gordon S, Jones Y, Kehrl JH, Kelm S, Le Douarin N, Powell L, Roder J, Schnaar RL, Sgroi D, Stamenkovic K, Schauer R, Schachner M, van den Berg TK, van der Merwe PA, Watt SM, Varki A (1998) Siglecs: a family of sialic-acid binding lectins. Glycobiology 8:v. https:\/\/doi.org\/10.1093\/oxfordjournals.glycob.a018832","journal-title":"Glycobiology"},{"key":"7_CR11","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nri2056","volume":"7","author":"PR Crocker","year":"2007","unstructured":"Crocker PR, Paulson JC, Varki A (2007) Siglecs and their roles in the immune system. Nat Rev Immunol 7:255\u2013266. https:\/\/doi.org\/10.1038\/nri2056","journal-title":"Nat Rev Immunol"},{"key":"7_CR12","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1107\/s0907444903018146","volume":"59","author":"N Dimasi","year":"2003","unstructured":"Dimasi N, Moretta L, Biassoni R, Mariuzza RA (2003) Expression, crystallization and preliminary crystallographic analysis of the extracellular IgV-like domain of the human natural killer cell inhibitory receptor p75\/AIRM1. Acta Crystallogr D Biol Crystallogr 59:1856\u20131858. https:\/\/doi.org\/10.1107\/s0907444903018146","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"7_CR13","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1107\/S0907444903028439","volume":"60","author":"N Dimasi","year":"2004","unstructured":"Dimasi N, Moretta A, Moretta L, Biassoni R, Mariuzza RA (2004) Structure of the saccharide-binding domain of the human natural killer cell inhibitory receptor p75\/AIRM1. Acta Crystallogr D Biol Crystallogr 60:401\u2013403. https:\/\/doi.org\/10.1107\/S0907444903028439","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"7_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2022.101110","volume":"90","author":"A Gonzalez-Gil","year":"2023","unstructured":"Gonzalez-Gil A, Li TA, Kim J, Schnaar RL (2023) Human sialoglycan ligands for immune inhibitory Siglecs. Mol Asp Med 90:101110. https:\/\/doi.org\/10.1016\/j.mam.2022.101110","journal-title":"Mol Asp Med"},{"key":"7_CR15","doi-asserted-by":"publisher","first-page":"10833","DOI":"10.1074\/jbc.RA118.007083","volume":"294","author":"N Hashimoto","year":"2019","unstructured":"Hashimoto N, Ito S, Tsuchida A, Bhuiyan RH, Okajima T, Yamamoto A, Furukawa K, Ohmi Y (2019) The ceramide moiety of disialoganglioside (GD3) is essential for GD3 recognition by the sialic acid-binding lectin SIGLEC7 on the cell surface. J Biol Chem 294:10833\u201310845. https:\/\/doi.org\/10.1074\/jbc.RA118.007083","journal-title":"J Biol Chem"},{"key":"7_CR16","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.3390\/ijms19041073","volume":"19","author":"CH Huang","year":"2018","unstructured":"Huang CH, Liao YJ, Fan TH, Chiou TJ, Lin YH, Twu YC (2018) A developed NK-92MI cell line with Siglec-7. Int J Mol Sci 19:1073. https:\/\/doi.org\/10.3390\/ijms19041073","journal-title":"Int J Mol Sci"},{"key":"7_CR17","doi-asserted-by":"publisher","first-page":"43117","DOI":"10.1074\/jbc.M403538200","volume":"279","author":"Y Ikehara","year":"2004","unstructured":"Ikehara Y, Ikehara SK, Paulson JC (2004) Negative regulation of T cell receptor signaling by Siglec-7 (p70\/AIRM) and Siglec-9. J Biol Chem 279:43117\u201343125. https:\/\/doi.org\/10.1074\/jbc.M403538200","journal-title":"J Biol Chem"},{"key":"7_CR18","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/s0014-5793(01)02734-x","volume":"504","author":"A Ito","year":"2001","unstructured":"Ito A, Handa K, Withers DA, Satoh M, Hakomori S (2001) Binding specificity of siglec7 to disialogangliosides of renal cell carcinoma: possible role of disialogangliosides in tumor progression. FEBS Lett 504:82\u201386. https:\/\/doi.org\/10.1016\/s0014-5793(01)02734-x","journal-title":"FEBS Lett"},{"key":"7_CR19","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1158\/2326-6066.CIR-22-0366","volume":"10","author":"H L\u00e4ubli","year":"2022","unstructured":"L\u00e4ubli H, Nalle SC, Maslyar D (2022) Targeting the Siglec-sialic acid immune axis in cancer: current and future approaches. Cancer Immunol Res 10:1423\u20131432. https:\/\/doi.org\/10.1158\/2326-6066.CIR-22-0366","journal-title":"Cancer Immunol Res"},{"key":"7_CR20","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/s1097-2765(00)80071-4","volume":"1","author":"AP May","year":"1998","unstructured":"May AP, Robinson RC, Vinson M, Crocker PR, Jones EY (1998) Crystal structure of the N-terminal domain of sialoadhesin in complex with 3\u2032 sialyllactose at 1.85 A resolution. Mol Cell 1:719\u2013728. https:\/\/doi.org\/10.1016\/s1097-2765(00)80071-4","journal-title":"Mol Cell"},{"key":"7_CR21","doi-asserted-by":"publisher","first-page":"23003","DOI":"10.1074\/jbc.M111.244152","volume":"286","author":"N Mitra","year":"2011","unstructured":"Mitra N, Banda K, Altheide TK, Schaffer L, Johnson-Pais TL, Beuten J, Leach RJ, Angata T, Varki N, Varki A (2011) SIGLEC12, a human-specific segregating (pseudo)gene, encodes a signaling molecule expressed in prostate carcinomas. J Biol Chem 286:23003\u201323011. https:\/\/doi.org\/10.1074\/jbc.M111.244152","journal-title":"J Biol Chem"},{"key":"7_CR22","doi-asserted-by":"publisher","first-page":"4498","DOI":"10.1158\/0008-5472.CAN-03-3614","volume":"64","author":"K Miyazaki","year":"2004","unstructured":"Miyazaki K, Ohmori K, Izawa M, Koike T, Kumamoto K, Furukawa K, Ando T, Kiso M, Yamaji T, Hashimoto Y, Suzuki A, Yoshida A, Takeuchi M, Kannagi R (2004) Loss of disialyl Lewis(a), the ligand for lymphocyte inhibitory receptor sialic acid-binding immunoglobulin-like lectin-7 (Siglec-7) associated with increased sialyl Lewis (a) expression on human colon cancers. Cancer Res 64:4498\u20134505. https:\/\/doi.org\/10.1158\/0008-5472.CAN-03-3614","journal-title":"Cancer Res"},{"key":"7_CR23","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/978-981-19-7732-9_3","volume-title":"Glycosignals in cancer","author":"S Morishita","year":"2023","unstructured":"Morishita S, Hane M, Kitajima K, Sato C (2023) Substantial basis for Glyco-assembly: Siglec7 and synthetic sialylpolymer. In: Furukawa K, Fukuda M (eds) Glycosignals in cancer. Springer, Singapore, pp 35\u201352. https:\/\/doi.org\/10.1007\/978-981-19-7732-9_3"},{"key":"7_CR24","doi-asserted-by":"publisher","first-page":"34089","DOI":"10.1074\/jbc.274.48.34089","volume":"274","author":"G Nicoll","year":"1999","unstructured":"Nicoll G, Ni J, Liu D, Klenerman P, Munday J, Dubock S, Mattei MG, Crocker PR (1999) Identification and characterization of a novel siglec, siglec-7, expressed by human natural killer cells and monocytes. J Biol Chem 274:34089\u201334095. https:\/\/doi.org\/10.1074\/jbc.274.48.34089","journal-title":"J Biol Chem"},{"key":"7_CR25","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1002\/eji.200323693","volume":"33","author":"G Nicoll","year":"2003","unstructured":"Nicoll G, Avril T, Lock K, Furukawa K, Bovin N, Crocker P (2003) Ganglioside GD3 expression on target cells can modulate NK cell cytotoxicity via siglec-7-dependent and -independent mechanisms. Eur J Immunol 33:1642\u20131648. https:\/\/doi.org\/10.1002\/eji.200323693","journal-title":"Eur J Immunol"},{"key":"7_CR26","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1039\/c6cc07115e","volume":"53","author":"S Ohira","year":"2017","unstructured":"Ohira S, Yasuda Y, Tomita I, Kitajima K, Takahashi T, Sato C, Tanaka H (2017) Synthesis of end-functionalized glycopolymers containing \u03b1(2,8) disialic acids via \u03c0-allyl nickel catalyzeoordinating polymerization and their interaction with Siglec-7. Chem Commun (Camb) 53:553\u2013556. https:\/\/doi.org\/10.1039\/c6cc07115e","journal-title":"Chem Commun (Camb)"},{"key":"7_CR27","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/s0960-894x(02)00998-8","volume":"13","author":"E Rapoport","year":"2003","unstructured":"Rapoport E, Mikhalyov I, Zhang J, Crocker P, Bovin N (2003) Ganglioside binding pattern of CD33-related siglecs. Bioorg Med Chem Lett 13:675\u2013678. https:\/\/doi.org\/10.1016\/s0960-894x(02)00998-8","journal-title":"Bioorg Med Chem Lett"},{"key":"7_CR28","doi-asserted-by":"publisher","first-page":"11014","DOI":"10.1002\/anie.201205831","volume":"51","author":"CD Rillahan","year":"2012","unstructured":"Rillahan CD, Schwartz E, McBride R, Fokin VV, Paulson JC (2012) Click and pick: identification of sialoside analogues for siglec-baseell targeting. Angew Chem Int Ed Engl 51:11014\u201311018. https:\/\/doi.org\/10.1002\/anie.201205831","journal-title":"Angew Chem Int Ed Engl"},{"key":"7_CR29","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1021\/cb400125w","volume":"8","author":"CD Rillahan","year":"2013","unstructured":"Rillahan CD, Schwartz E, Rademacher C, McBride R, Rangarajan J, Fokin VV, Paulson JC (2013) On-chip synthesis and screening of a sialoside library yields a high affinity ligand for Siglec-7. ACS Chem Biol 8:1417\u20131422. https:\/\/doi.org\/10.1021\/cb400125w","journal-title":"ACS Chem Biol"},{"key":"7_CR30","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1007\/s12026-017-8942-y","volume":"65","author":"P Rosenstock","year":"2017","unstructured":"Rosenstock P, Horstkorte R, Gnanapragassam VS, Harth J, Kielstein H (2017) Siglec-7 expression is reduced on a natural killer (NK) cell subset of obese humans. Immunol Res 65:1017\u20131024. https:\/\/doi.org\/10.1007\/s12026-017-8942-y","journal-title":"Immunol Res"},{"key":"7_CR31","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1093\/jb\/mvt057","volume":"154","author":"C Sato","year":"2013","unstructured":"Sato C, Kitajima K (2013) Disialic, oligosialic and polysialic acids: distribution, functions and related disease. J Biochem 154:115\u2013136. https:\/\/doi.org\/10.1093\/jb\/mvt057","journal-title":"J Biochem"},{"key":"7_CR32","doi-asserted-by":"publisher","unstructured":"Sato, C., Kitajima, K., Inoue, S., Seki, T., Troy, F.A., Inoue, Y., 1995. Characterization of the antigenic specificity of four different anti-(alpha 2-->8-linked polysialic acid) antibodies using lipionjugated oligo\/polysialic acids. J Biol Chem 270, 18923\u201318928. https:\/\/doi.org\/10.1074\/jbc.270.32.18923","DOI":"10.1074\/jbc.270.32.18923"},{"key":"7_CR33","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/sji.12455","volume":"84","author":"JY Shao","year":"2016","unstructured":"Shao JY, Yin WW, Zhang QF, Liu Q, Peng ML, Hu HD, Hu P, Ren H, Zhang DZ (2016) Siglec-7 defines a highly functional natural killer cell subset and inhibits cell-mediated activities. Scand J Immunol 84:182\u2013190. https:\/\/doi.org\/10.1111\/sji.12455","journal-title":"Scand J Immunol"},{"key":"7_CR34","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1006\/jmbi.1997.1432","volume":"274","author":"DK Smith","year":"1997","unstructured":"Smith DK, Xue H (1997) Sequence profiles of immunoglobulin and immunoglobulin-like domains. J Mol Biol 274:530\u2013545. https:\/\/doi.org\/10.1006\/jmbi.1997.1432","journal-title":"J Mol Biol"},{"key":"7_CR35","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aab3459","volume":"7","author":"S Spence","year":"2015","unstructured":"Spence S, Greene MK, Fay F, Hams E, Saunders SP, Hamid U, Fitzgerald M, Beck J, Bains BK, Smyth P, Themistou E, Small DM, Schmid D, O\u2019Kane CM, Fitzgerald M, Abdelghany SM, Johnston JA, Fallon PG, Burrows JF, McAuley DF, Kissenpfennig A, Scott CJ (2015) Targeting Siglecs with a sialic acid-decorated nanoparticle abrogates inflammation. Sci Transl Med 7:303ra140. https:\/\/doi.org\/10.1126\/scitranslmed.aab3459","journal-title":"Sci Transl Med"},{"key":"7_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2023.105579","volume":"300","author":"N Stewart","year":"2024","unstructured":"Stewart N, Daly J, Drummond-Guy O, Krishnamoorthy V, Stark JC, Riley NM, Williams KC, Bertozzi CR, Wisnovsky S (2024) The glycoimmune checkpoint receptor Siglec-7 interacts with T-cell ligands and regulates T-cell activation. J Biol Chem 300:105579. https:\/\/doi.org\/10.1016\/j.jbc.2023.105579","journal-title":"J Biol Chem"},{"key":"7_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0045821","volume":"7","author":"S Varchetta","year":"2012","unstructured":"Varchetta S, Brunetta E, Roberto A, Mikulak J, Hudspeth KL, Mondelli MU, Mavilio D (2012) Engagement of Siglec-7 receptor induces a pro-inflammatory response selectively in monocytes. PLoS One 7:e45821. https:\/\/doi.org\/10.1371\/journal.pone.0045821","journal-title":"PLoS One"},{"key":"7_CR38","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1136\/gutjnl-2015-310327","volume":"65","author":"S Varchetta","year":"2016","unstructured":"Varchetta S, Mele D, Lombardi A, Oliviero B, Mantovani S, Tinelli C, Spreafico M, Prati D, Ludovisi S, Ferraioli G, Filice C, Aghemo A, Lampertico P, Facchetti F, Bernuzzi F, Invernizzi P, Mondelli MU (2016) Lack of Siglec-7 expression identifies a dysfunctional natural killer cell subset associated with liver inflammation and fibrosis in chronic HCV infection. Gut 65:1998\u20132006. https:\/\/doi.org\/10.1136\/gutjnl-2015-310327","journal-title":"Gut"},{"key":"7_CR39","doi-asserted-by":"publisher","first-page":"9267","DOI":"10.1074\/jbc.271.16.9267","volume":"271","author":"M Vinson","year":"1996","unstructured":"Vinson M, van der Merwe PA, Kelm S, May A, Jones EY, Crocker PR (1996) Characterization of the sialic acid-binding site in sialoadhesin by site-directed mutagenesis. J Biol Chem 271:9267\u20139272. https:\/\/doi.org\/10.1074\/jbc.271.16.9267","journal-title":"J Biol Chem"},{"key":"7_CR40","doi-asserted-by":"publisher","unstructured":"Wisnovsky S, M\u00f6ckl L, Malaker SA, Pedram K, Hess GT, Riley NM, Gray MA, Smith BAH, Bassik MC, Moerner WE, Bertozzi CR (2021) Genome-wide CRISPR screens reveal a specific ligand for the glycan-binding immune checkpoint receptor Siglec-7. Proc Natl Acad Sci USA 118. https:\/\/doi.org\/10.1073\/pnas.2015024118","DOI":"10.1073\/pnas.2015024118"},{"key":"7_CR41","doi-asserted-by":"publisher","first-page":"10304","DOI":"10.1073\/pnas.1608069113","volume":"113","author":"H Xiao","year":"2016","unstructured":"Xiao H, Woods EC, Vukojicic P, Bertozzi CR (2016) Precision glycocalyx editing as a strategy for cancer immunotherapy. Proc Natl Acad Sci USA 113:10304\u201310309. https:\/\/doi.org\/10.1073\/pnas.1608069113","journal-title":"Proc Natl Acad Sci USA"},{"key":"7_CR42","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1002\/cbic.201600694","volume":"18","author":"S Yamaguchi","year":"2017","unstructured":"Yamaguchi S, Yoshimura A, Yasuda Y, Mori A, Tanaka H, Takahashi T, Kitajima K, Sato C (2017) Chemical synthesis and evaluation of a disialic acid containing dextran polymer as an inhibitor for the interaction between Siglec 7 and its ligand. ChemBioChem 18:1194\u20131203. https:\/\/doi.org\/10.1002\/cbic.201600694","journal-title":"ChemBioChem"},{"key":"7_CR43","doi-asserted-by":"publisher","first-page":"6324","DOI":"10.1074\/jbc.M110146200","volume":"277","author":"T Yamaji","year":"2002","unstructured":"Yamaji T, Teranishi T, Alphey MS, Crocker PR, Hashimoto Y (2002) A small region of the natural killer cell receptor, Siglec-7, is responsible for its preferred binding to alpha 2,8-disialyl and branched alpha 2,6-sialyl residues. A comparison with Siglec-9. J Biol Chem 277:6324\u20136332. https:\/\/doi.org\/10.1074\/jbc.M110146200","journal-title":"J Biol Chem"},{"key":"7_CR44","doi-asserted-by":"publisher","first-page":"8647","DOI":"10.1038\/s41598-020-64887-4","volume":"10","author":"N Yamakawa","year":"2020","unstructured":"Yamakawa N, Yasuda Y, Yoshimura A, Goshima A, Crocker PR, Vergoten G, Nishiura Y, Takahashi T, Hanashima S, Matsumoto K, Yamaguchi Y, Tanaka H, Kitajima K, Sato C (2020) Discovery of a new sialic acid binding region that regulates Siglec-7. Sci Rep 10:8647. https:\/\/doi.org\/10.1038\/s41598-020-64887-4","journal-title":"Sci Rep"},{"key":"7_CR45","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/j.bbrc.2020.10.023","volume":"534","author":"A Yoshimura","year":"2020","unstructured":"Yoshimura A, Hatanaka R, Tanaka H, Kitajima K, Sato C (2020) The conserved arginine residue in all Siglecs is essential for Siglec-7 binding to sialic acid. Biochem Biophys Res Commun 534:1069\u20131075. https:\/\/doi.org\/10.1016\/j.bbrc.2020.10.023","journal-title":"Biochem Biophys Res Commun"},{"key":"7_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.100477","volume":"296","author":"A Yoshimura","year":"2021","unstructured":"Yoshimura A, Asahina Y, Chang LY, Angata T, Tanaka H, Kitajima K, Sato C (2021) Identification and functional characterization of a Siglec-7 counter-receptor on K562 cells. J Biol Chem 296:100477. https:\/\/doi.org\/10.1016\/j.jbc.2021.100477","journal-title":"J Biol Chem"}],"container-title":["Advances in Experimental Medicine and Biology","The Molecular Immunology of Complex Carbohydrates - 4"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-032-04153-1_7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T23:28:54Z","timestamp":1774999734000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-032-04153-1_7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9783032041524","9783032041531"],"references-count":46,"URL":"https:\/\/doi.org\/10.1007\/978-3-032-04153-1_7","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"1 April 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}